Providing solutions for professionals working in reproductive medicine
The basis of our products lies in research intended to fulfill the needs of professionals and their patients.
All of the research projects performed at Igenomix are intended for clinical use.
Igenomix actively works in research and has organized and participated in a vast number of national and international talks and conferences.
The result of this hard work has led to the publication of an extensive array of peer reviewed articles.
At Igenomix, we are involved in the full development process of diagnostic tests: from the original concept, undertaking clinical studies, producing and analysing results, to their transfer to become products available to the healthcare industry.
In the Products Development Department, we do not merely adapt already established procedures, but we innovate to provide our patients with the best services.
Application number: PCT/ES2009/000386
Gene expression profile as an endometrial receptivity marker (ERA)
07/22/2009
Application number: PCT/EP2020/060878
Leiomyosarcomas I
Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas.
17.04.20
Application number: 62/686,621
Methods, compositions and kits for assessing endometrial transformation
06/18/2018
Application number: EP21382915.3
Leiomyosarcomas II
Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas.
11.10.21
Status: Pending
Since its inception, Igenomix has actively worked to apply research to reproductive health. This effort is now being supported by several financial agencies through the projects indicated below.
Sex selection and Sex determination, before and after conception is prohibited and punishable under PC & PNDT act no. 57 of 1994
IGENOMIX has not affiliated any news outlet or publication identified above. News coverage does not constitute an endorsement of IGENOMIX or its products
